Nicolas LOISEAU papers

before joining the lab

2007

Meissonnier GM, Laffitte J, Loiseau N, Benoit E, Raymond I, Pinton P, Cossalter AM, Bertin G, Oswald IP, Galtier P. Selective impairment of drug-metabolizing enzymes in pig liver during subchronic dietary exposure to aflatoxin B1. Food Chem Toxicol. 2007, 45(11):2145-54.

Gouze ME, Laffitte J, Pinton P, Dedieux G, Galinier A, Thouvenot JP, Loiseau N, Oswald IP, Galtier P. Effect of subacute oral doses of nivalenol on immune and metabolic defence systems in mice. Vet Res. 2007, 38(4):635-46.

Loiseau N, Debrauwer L, Sambou T, Bouhet S, Miller JD, Martin PG, Viadère JL, Pinton P, Puel O, Pineau T, Tulliez J, Galtier P, Oswald IP. Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids, glycolipids and trans-epithelial passage disturbance. Biochem Pharmacol. 2007, 74(1):144-52.

Khoufache K, Puel O, Loiseau N, Delaforge M, Rivollet D, Coste A, Cordonnier C, Escudier E, Botterel F, Bretagne S. Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells. BMC Microbiol. 2007, 7:5.

2006

Gouze ME, Laffitte J, Rouimi P, Loiseau N, Oswald IP, Galtier P. Effect of various doses of deoxynivalenol on liver xenobiotic metabolizing enzymes in mice. Food Chem Toxicol. 2006, 44(4):476-83.

2004

Bouhet S, Hourcade E, Loiseau N, Fikry A, Martinez S, Roselli M, Galtier P, Mengheri E, Oswald IP. The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol Sci. 2004, 77(1):165-71.

2003

Loiseau N, Gomis JM, Santolini J, Delaforge M, André F. Predicting the conformational states of cyclic tetrapeptides. Biopolymers. 2003, 69(3):363-85.

2002

Garrigues A, Loiseau N, Delaforge M, Ferté J, Garrigos M, André F, Orlowski S. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. Mol Pharmacol. 2002, 62(6):1288-98.

Loiseau N, Cavelier F, Noel JP, Gomis JM. High yield synthesis of tentoxin, a cyclic tetrapeptide. J Pept Sci. 2002, 8(7):335-46.

2001

Loiseau N, Delaforge M, Minoletti C, André F, Garrigues A, Orlowski S, Gomis JM. Structure-activity relationships of cyclotetrapeptides: interaction of tentoxin derivatives with three membrane proteins. Adv Exp Med Biol. 2001;500:343-6.